BioLife Solutions, Inc. (BLFS)
35.93
+0.46
(+1.30%)
USD |
NASDAQ |
Sep 02, 16:00
35.93
0.00 (0.00%)
After-Hours: 16:04
BioLife Solutions Research and Development Expense (Annual) : 7.566M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 7.566M |
| December 31, 2024 | 4.751M |
| December 31, 2023 | 12.07M |
| December 31, 2022 | 14.80M |
| December 31, 2021 | 11.82M |
| December 31, 2020 | 6.72M |
| December 31, 2019 | 3.168M |
| December 31, 2018 | 1.298M |
| December 31, 2017 | 1.193M |
| December 31, 2016 | 2.028M |
| December 31, 2015 | 1.379M |
| December 31, 2014 | 0.8711M |
| December 31, 2013 | 0.4878M |
| December 31, 2012 | 0.4636M |
| December 31, 2011 | 0.5165M |
| December 31, 2010 | 0.3189M |
| Date | Value |
|---|---|
| December 31, 2009 | 0.4145M |
| December 31, 2008 | 0.4576M |
| December 31, 2007 | 0.4134M |
| December 31, 2006 | 0.0573M |
| December 31, 2005 | 0.0279M |
| December 31, 2004 | 0.0291M |
| December 31, 2003 | 0.7593M |
| December 31, 2002 | 0.6448M |
| December 31, 2001 | 1.773M |
| December 31, 2000 | 1.374M |
| December 31, 1999 | 0.6874M |
| December 31, 1998 | 0.6742M |
| December 31, 1997 | 1.294M |
| December 31, 1996 | 1.235M |
| June 30, 1995 | 2.900M |
| June 30, 1994 | 2.506M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Repligen Corp. | 51.31M |
| Agilent Technologies, Inc. | 450.00M |
| Danaher Corp. | 1.598B |
| Thermo Fisher Scientific, Inc. | 1.397B |
| West Pharmaceutical Services, Inc. | 74.30M |